Christopher Dolan, MD
MOHS-Micrographic Surgery · Bethesda, MDNPI 1497717532
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 43.6% of the total. Reporting peaked in 2019 at $293 and has fallen 59.7% since, to $118 in 2024. That places this record below the midpoint for mohs-micrographic surgery clinicians in MD, where the typical reported total is $858.
Across 9 payments — averaging $54.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$216
- Journey Medical Corporation$99
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$77
- Sanofi$39
- Incyte Corporation$31
- Verrica Pharmaceuticals Inc.$20
- plus $14 from 1 others
What the payments were for
- Food & beverage$494100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 2 | $216 |
| Journey Medical Corporation | 1 | $99 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $77 |
| Sanofi | 1 | $39 |
| Incyte Corporation | 2 | $31 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$118
How this compares
$494 in reported general payments places this provider in the 25th percentile of 26 mohs-micrographic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 390 | $4,931 |
| Gentamicin Sulfate | 124 | $4,548 |
| Mupirocin | 226 | $1,702 |
| Cephalexin | 205 | $1,075 |
| Doxycycline Hyclate | 72 | $628 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $51 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Bethesda
- Kara HoversonBethesda$858
- Mark WelchBethesda$733
- Sabrina HouseBethesda$225
- Jeffrey LackeyBethesda$75
- Andrew MontemaranoBethesda$16
- Cylburn SodenLaurel$201K
- Michael WarnerFrederick$31K
- Trinh PhamTowson$10K
- Julia Santoso-PhamTowson$10K
- Hyland CroninChevy Chase$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.